Showing results (1-10 of 2,471) with videos related to

Sort By:
Pageof 248
Cancer|July 18, 2000
Biochemical markers and skeletal metastasesL M Demers, L Costa, A Lipton
The Canadian Journal of Oncology|December 1, 1995
Bone markers in osteoporosis and malignancyA Lipton, L Costa, L M Demers
Cancer Treatment Reviews|June 22, 2001
Bone markers in the management of metastatic bone diseaseA Lipton, L Costa, S M Ali, et al.
Clinical Chemistry|October 1, 1995
Biochemical markers of bone turnover in patients with metastatic bone diseaseL M Demers, L Costa, V M Chinchilli, et al.
Seminars in Oncology|September 7, 2001
Use of markers of bone turnover for monitoring bone metastases and the response to therapyA Lipton, L Costa, S Ali, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
The effects of long term fadrozole hydrochloride treatment in patients with advanced stage breast cancerL M Demers, A Lipton, H A Harvey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasisS M Ali, L M Demers, K Leitzel, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
Inhibition of aromatase with CGS 16949A in postmenopausal womenR J Santen, L M Demers, H Adlercreutz, et al.
Breast Cancer Research and Treatment|January 1, 1995
Aromatase inhibitor development for treatment of breast cancerS Masamura, H Adlercreutz, H Harvey, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesisL M Demers, J C Melby, T E Wilson, et al.
Pageof 248